Products

AlleFlow

AI-native

Build, run and repair workflows without the complexity

alleflow.com AI Models & Agents / Agent Builders & Platforms

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Unknown
Freemium model, plan pricing not identified yet
Creators
iam JB
No social account linked
Launched
3mo ago
2026-08-24 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    AI that builds, runs, and fixes your workflows

    Aug 24 · 3mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2026-03-17

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Free Trial
Free
3 workflows · 5,000 node executions/month · 60 node executions/minute · 10 AI credits/month

Trial: None · Free tier included · Observed 2026-11-06 · Source page

Pages & changes

Tracked since 2026-08-24

Key pages

Weekly snapshots
alleflow.com/ Snapshot 2026-11-06

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much does AlleFlow cost?
Free Trial: Free. Observed 2026-11-06. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does AlleFlow get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is AlleFlow and what platforms does it support?
AlleFlow is catalogued under Agent Builders & Platforms: Build, run and repair workflows without the complexity. Supported platforms: Browser Extension, API.

Related products in this category

AI Models & Agents / Agent Builders & Platforms

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.